Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
56.38
-2.01 (-3.44%)
Apr 29, 2026, 3:04 PM CST
SHE:300347 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 771.46 | 887.89 | 405.14 | 2,025 | 2,007 | 2,874 | Upgrade
|
| Depreciation & Amortization | 326.74 | 326.74 | 324.14 | 305.69 | 264.75 | 188.92 | Upgrade
|
| Other Amortization | 42.81 | 42.81 | 39.9 | 33.34 | 20.1 | 7.84 | Upgrade
|
| Loss (Gain) From Sale of Assets | -3.65 | -3.65 | -3.56 | 0.19 | 0.09 | 0.53 | Upgrade
|
| Asset Writedown & Restructuring Costs | 21.58 | 21.58 | 5 | 29.16 | 0.45 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -476.07 | -476.07 | 335.05 | -690.95 | -638.61 | -2,128 | Upgrade
|
| Provision & Write-off of Bad Debts | 14.81 | 14.81 | 29.73 | 36.68 | 23.86 | 25.72 | Upgrade
|
| Other Operating Activities | 262.54 | 26.34 | 165.19 | 244.62 | 328.93 | 552.99 | Upgrade
|
| Change in Accounts Receivable | -199.8 | -199.8 | -1,017 | -719.47 | -869.25 | -808.73 | Upgrade
|
| Change in Inventory | -9.52 | -9.52 | 3.66 | -4.36 | -16.11 | -1.37 | Upgrade
|
| Change in Accounts Payable | 511.49 | 511.49 | 751.59 | -111.55 | 193.78 | 575.03 | Upgrade
|
| Change in Other Net Operating Assets | 23.68 | 23.68 | 64.89 | 16.09 | 50.53 | 92.26 | Upgrade
|
| Operating Cash Flow | 1,238 | 1,118 | 1,097 | 1,150 | 1,358 | 1,424 | Upgrade
|
| Operating Cash Flow Growth | 7.57% | 1.92% | -4.64% | -15.25% | -4.66% | 42.57% | Upgrade
|
| Capital Expenditures | -216.7 | -214.37 | -356.55 | -313.76 | -448.6 | -368.62 | Upgrade
|
| Sale of Property, Plant & Equipment | 6.17 | 5.93 | 2.34 | 5.31 | 2.02 | 1.43 | Upgrade
|
| Cash Acquisitions | -163.09 | -164.95 | -362.65 | -351.29 | -663.09 | -318.46 | Upgrade
|
| Divestitures | - | - | - | - | - | 67.1 | Upgrade
|
| Investment in Securities | 920.33 | 274.98 | -4,088 | -972.68 | -1,779 | -2,156 | Upgrade
|
| Other Investing Activities | 656.95 | 589.96 | 74.26 | 98.19 | 99.7 | -7.84 | Upgrade
|
| Investing Cash Flow | 1,204 | 491.56 | -4,739 | -1,534 | -2,789 | -2,783 | Upgrade
|
| Long-Term Debt Issued | - | 1,138 | 3,379 | 3,201 | 3,441 | 492.32 | Upgrade
|
| Long-Term Debt Repaid | - | -2,510 | -4,032 | -2,666 | -1,953 | -90.58 | Upgrade
|
| Net Debt Issued (Repaid) | -1,533 | -1,372 | -652.98 | 534.89 | 1,489 | 401.74 | Upgrade
|
| Issuance of Common Stock | 336.37 | 284.23 | 133.12 | 395.55 | 339.12 | 288.94 | Upgrade
|
| Repurchase of Common Stock | -397.06 | -397.06 | -270.89 | -29.85 | -426.6 | -515.95 | Upgrade
|
| Common Dividends Paid | -331.57 | -343.66 | -642.16 | -589.87 | -492 | -284.23 | Upgrade
|
| Other Financing Activities | 109.69 | -98.01 | -269.5 | -318.53 | -99.85 | -53.58 | Upgrade
|
| Financing Cash Flow | -1,815 | -1,927 | -1,702 | -7.81 | 809.25 | -163.09 | Upgrade
|
| Foreign Exchange Rate Adjustments | -28.26 | -8.84 | -6.92 | 8.79 | 26.93 | -59.56 | Upgrade
|
| Net Cash Flow | 598.02 | -325.89 | -5,351 | -382.8 | -595.68 | -1,582 | Upgrade
|
| Free Cash Flow | 1,021 | 903.72 | 740.45 | 836.68 | 908.9 | 1,055 | Upgrade
|
| Free Cash Flow Growth | 19.07% | 22.05% | -11.50% | -7.95% | -13.86% | 25.29% | Upgrade
|
| Free Cash Flow Margin | 14.44% | 13.23% | 11.21% | 11.33% | 12.83% | 20.24% | Upgrade
|
| Free Cash Flow Per Share | 1.21 | 1.06 | 0.86 | 0.97 | 1.05 | 1.21 | Upgrade
|
| Cash Income Tax Paid | 385.85 | 373.03 | 524.11 | 644.91 | 594.85 | 321.71 | Upgrade
|
| Levered Free Cash Flow | 1,034 | 888.56 | 183.61 | 316.13 | -115.55 | 712.29 | Upgrade
|
| Unlevered Free Cash Flow | 1,090 | 945.16 | 271.88 | 391.07 | -63.56 | 727.86 | Upgrade
|
| Change in Working Capital | 277.63 | 277.63 | -203.58 | -833.14 | -648.62 | -98.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.